Authors:
van der Burg, SH
Kwappenberg, KMC
O'Neill, T
Brandt, RMP
Melief, CJM
Hickling, JK
Offringa, R
Citation: Sh. Van Der Burg et al., Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens, VACCINE, 19(27), 2001, pp. 3652-3660